Header cover image

Canadian (TSX) Healthcare Sector Analysis

UpdatedOct 16, 2025
DataAggregated Company Financials
Companies125
  • 7D-1.3%
  • 3M31.2%
  • 1Y3.1%
  • YTD15.9%

Over the last 7 days, the Healthcare industry has dropped 1.3%, driven by WELL Health Technologies declining 14%. In contrast, Bright Minds Biosciences has gained 30%. This takes the industry's 12 month performance to a gain of 3.1%. Looking forward, earnings are forecast to grow by 55% annually.

Sector Valuation and Performance

Has the Canadian Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 17 Oct 2025CA$38.0bCA$19.5b-CA$2,324,329,502.1337.4x-16.3x1.9x
Sun, 14 Sep 2025CA$33.8bCA$19.4b-CA$2,309,057,574.7141.2x-14.6x1.7x
Tue, 12 Aug 2025CA$31.7bCA$19.7b-CA$2,698,143,101.0729x-11.8x1.6x
Thu, 10 Jul 2025CA$28.4bCA$19.5b-CA$2,787,249,766.7824.2x-10.2x1.5x
Sat, 07 Jun 2025CA$27.0bCA$19.5b-CA$2,818,943,002.6222.8x-9.6x1.4x
Mon, 05 May 2025CA$27.9bCA$19.5b-CA$2,751,222,867.3626x-10.1x1.4x
Wed, 02 Apr 2025CA$26.0bCA$20.0b-CA$2,842,550,155.5319.4x-9.1x1.3x
Fri, 28 Feb 2025CA$27.8bCA$19.9b-CA$2,506,042,121.4323.1x-11.1x1.4x
Sun, 26 Jan 2025CA$28.3bCA$19.8b-CA$2,714,894,200.5333.5x-10.4x1.4x
Tue, 24 Dec 2024CA$28.7bCA$19.8b-CA$2,739,171,100.1025x-10.5x1.4x
Thu, 21 Nov 2024CA$30.0bCA$19.9b-CA$2,939,873,055.8417.4x-10.2x1.5x
Sat, 19 Oct 2024CA$34.1bCA$19.4b-CA$2,973,484,725.3820.6x-11.5x1.8x
Mon, 16 Sep 2024CA$32.6bCA$19.3b-CA$2,982,041,003.5821.4x-10.9x1.7x
Wed, 14 Aug 2024CA$32.3bCA$19.2b-CA$3,142,515,822.5823.3x-10.3x1.7x
Fri, 12 Jul 2024CA$32.0bCA$19.1b-CA$3,643,813,555.4220x-8.8x1.7x
Sun, 09 Jun 2024CA$33.5bCA$19.4b-CA$3,302,737,566.3317.7x-10.1x1.7x
Tue, 07 May 2024CA$36.2bCA$19.2b-CA$3,994,047,069.5616.9x-9.1x1.9x
Thu, 04 Apr 2024CA$32.6bCA$17.9b-CA$4,056,486,376.9612.2x-8x1.8x
Sat, 02 Mar 2024CA$33.0bCA$19.3b-CA$5,027,415,033.3013.2x-6.6x1.7x
Mon, 29 Jan 2024CA$37.7bCA$20.1b-CA$7,670,250,299.0011.3x-4.9x1.9x
Wed, 27 Dec 2023CA$32.2bCA$19.9b-CA$7,642,151,504.0013.5x-4.2x1.6x
Fri, 24 Nov 2023CA$33.3bCA$20.2b-CA$7,873,898,101.0016.1x-4.2x1.6x
Sun, 22 Oct 2023CA$32.0bCA$20.0b-CA$8,402,080,042.0017.8x-3.8x1.6x
Tue, 19 Sep 2023CA$37.7bCA$20.5b-CA$8,932,134,692.0017.4x-4.2x1.8x
Thu, 17 Aug 2023CA$29.3bCA$20.6b-CA$9,155,157,306.0018.2x-3.2x1.4x
Sat, 15 Jul 2023CA$31.8bCA$20.5b-CA$10,798,080,127.0021.6x-2.9x1.5x
Mon, 12 Jun 2023CA$30.4bCA$20.6b-CA$11,518,392,382.0016x-2.6x1.5x
Wed, 10 May 2023CA$32.3bCA$20.5b-CA$11,289,182,243.0017x-2.9x1.6x
Fri, 07 Apr 2023CA$29.7bCA$21.6b-CA$11,375,301,085.0015.6x-2.6x1.4x
Sun, 05 Mar 2023CA$35.2bCA$21.9b-CA$11,713,199,174.0020x-3x1.6x
Tue, 31 Jan 2023CA$34.7bCA$21.8b-CA$11,518,550,574.0018.9x-3x1.6x
Thu, 29 Dec 2022CA$32.9bCA$22.0b-CA$11,584,404,749.0018.5x-2.8x1.5x
Sat, 26 Nov 2022CA$44.7bCA$21.7b-CA$11,740,897,241.0021.8x-3.8x2.1x
Mon, 24 Oct 2022CA$42.3bCA$21.5b-CA$10,902,086,794.0021.5x-3.9x2x
Price to Earnings Ratio

-3.9x


Total Market Cap: CA$42.3bTotal Earnings: -CA$10,902,086,794.00Total Revenue: CA$21.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Healthcare Sector Price to Earnings3Y Average -7.3x202320242025
Current Industry PE
  • Investors are optimistic on the Canadian Healthcare industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 1.6x is lower than the industry's current PS ratio of 1.9x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 3.1% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare sector?

CA Market0.73%
Healthcare-1.26%
Biotech0.88%
Pharma-0.0089%
Life Sciences-1.67%
Healthcare Services-2.55%
Healthtech-3.01%
Medical Equipment-6.80%
Industry PE
  • Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio.
    • Analysts are expecting annual earnings growth of 59.7%, which is higher than its past year's earnings growth of 11.1% per year.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 63% over the next 5 years.
  • This is better than its past earnings decline of 36% per year.
  • In contrast, the Life Sciences industry is expected to see its earnings decline by 48% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
METX ME Therapeutics HoldingsCA$6.8065.9%
+CA$79.9m
2.3%PB109.3x
DRUG Bright Minds BiosciencesCA$96.5012.3%
+CA$74.9m
221.7%PB13.2x
SHRX Sharp TherapeuticsCA$3.41135.2%
+CA$58.8m
n/aPB29.6x
EDT Spectral MedicalCA$1.5912.0%
+CA$49.0m
156.5%PS180.8x
HBFG Happy Belly Food GroupCA$1.6311.6%
+CA$22.1m
171.7%PS14.9x

Latest News